Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole was unchanged today. By the end of trading, Boston Scientific rose $0.19 (1.6%) to $11.82 on light volume. Throughout the day, 8,939,728 shares of Boston Scientific exchanged hands as compared to its average daily volume of 13,933,900 shares. The stock ranged in a price between $11.54-$11.82 after having opened the day at $11.62 as compared to the previous trading day's close of $11.63. Other companies within the Health Services industry that increased today were: EnteroMedics ( ETRM), up 63.5%, Unilife Corporation ( UNIS), up 16.6%, Baxano Surgical ( BAXS), up 13.5% and Retractable Technologies ( RVP), up 11.1%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.5 billion and is part of the health care sector. Shares are up 102.1% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Vision-Sciences Inc (DE ( VSCI), down 10.8%, Thermogenesis Corporation ( KOOL), down 10.4%, Health Insurance Innovations ( HIIQ), down 9.0% and AcelRx Pharmaceuticals ( ACRX), down 7.2% , were all laggards within the health services industry with Baxter International ( BAX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

Goldman Is Bullish on Oil, Sees Demand Outweighing Inventory Concern

Goldman Is Bullish on Oil, Sees Demand Outweighing Inventory Concern

Jim Cramer: Centene Is in All the Big Medicare Markets

Jim Cramer: Centene Is in All the Big Medicare Markets

Jim Cramer on the Markets: I Struggle With How Negative Things Are

Jim Cramer on the Markets: I Struggle With How Negative Things Are

Video: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene